Benjamin Chen, MD, PhD, of the Icahn School of Medicine at Mount Sinai, discusses the implications of his new study involving ...

Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.

As an HIV researcher for many years, I want to address Dr. Neal Barnard’s dismissive claims in his op-ed in The ...

Determinants of HIV cell tropism & chemokine receptor usage ... exhibit a strong resistance to HIV infection and delayed progression to AIDS, respectively. A single-nucleotide polymorphism in ...

At current levels, we believe GILD scores above BMY, buoyed by solid fundamentals, potential approval of lenacapavir for HIV ...

HIV, or Human Immunodeficiency Virus, is a type of virus that weakens the immune system, making one susceptible to a variety of infections. Although there is no cure for HIV, with the right treatment, ...

Health Secretary Robert F. Kennedy Jr.’s purge of tens of thousands of federal workers has halted efforts to collect data on everything from cancer rates in firefighters to mother-to-baby transmission ...

Researchers at UW are pioneering long-acting injectable HIV therapies that have the potential to simplify and expand ...

Mar. 19, 2025 — New study demonstrates how high-affinity B cells 'bank' their best traits ... Kidney Transplantation Among Those With HIV Infections Shown Safe and Effective, Study Suggests ...

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

Child health experts have warned parents against using harmful practices to treat ear infections in children, cautioning that ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine ...